Collins, S L <br/><br/>
Kappa opioid agonists alter dopamine markers and cocaine-stimulated locomotor activity.  [electronic resource] 

 -  Behavioural pharmacology  Jul 2001 
 - 237-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0955-8810 
<br/><br/><label>Standard No.: </label>10.1097/00008877-200107000-00002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analgesics--pharmacology<br/>Animals<br/>Benzeneacetamides<br/>Benzomorphans--pharmacology<br/>Caudate Nucleus--drug effects<br/>Cocaine--pharmacology<br/>Dopamine--metabolism<br/>Dopamine Plasma Membrane Transport Proteins<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Male<br/>Membrane Glycoproteins<br/>Membrane Transport Proteins--drug effects<br/>Motor Activity--drug effects<br/>Naltrexone--pharmacology<br/>Nerve Net--drug effects<br/>Nerve Tissue Proteins<br/>Pyrrolidines--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Opioid, kappa--agonists